BeiGene Stock

Detail Data
Volume (24h): 8,853,456 shares
P/E Ratio: /
Forward P/E: -96.09
EPS: -3.66 HKD
Forward EPS: -1.38 HKD
Number of Shares: 1,285,299,968 shares
Market Capitalization: 197,506,383,872.00 HKD

Dividend

Dividend Value
Dividend Amount According to our data, the company BeiGene does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a strong_buy recommendation for BeiGene stock. The current number of analysts covering this company is 17. The highest target price is 234.9346 HKD, while the lowest target price is 148.90408 HKD. The median target valuation set by analysts is 197.82903 HKD. These forecasts and recommendations provide insight into how analysts view the future stock performance of BeiGene.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for BeiGene stock is: strong_buy
Number of Analysts: 17
Highest Target Price: 234.9346 HKD
Lowest Target Price: 148.90408 HKD
Median Target Price: 197.82903 HKD

Fundamental Indicators

Indicator Data
Total Revenue: 3,810,241,024.00 HKD
Net Income: -644,785,984.00 HKD
Price-to-Book (P/B): 4.25
PEG Ratio: /
Exchange: HKSE
Industry: Biotechnology
Sector: Healthcare
Number of Employees: 10000
Country: Cayman Islands

Where to Buy BeiGene Stock?

You can purchase BeiGene stock on the HKSE under the ticker symbol: 6160.HK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on BeiGene Stock

Indicator Value
Company Revenue: 3,810,241,024.00 HKD
EBITDA: -401,976,992.00 HKD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -3.66 HKD
Book Value Per Share: 31.22 HKD
Total Cash: 2,627,409,920.00 HKD
Total Cash per Share: 1.89 HKD
Total Debt: 1,079,865,984.00 HKD
Debt to Equity Ratio: 0.32
Quick Ratio 1.51
Current Ratio 1.80
Free Cash Flow -366,995,264.00 HKD
Operating Cash Flow -140,631,008.00 HKD
Gross Margins 84.41 %
EBITDA Margins -10.55 %
Operating Margins -6.31 %
Profit Margins -16.92 %
Return on Assets -6.1 %
Return on Equity -18.8 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 84.8 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 197,506,383,872.00 HKD
Enterprise Value 224,454,656,000.00 HKD
EV/Revenue 58.908
EV/EBITDA -558.377
Float Shares 958,920,813 shares
Shares Outstanding 1,285,299,968 shares
Held Percent Insiders 0.15 %
Held Percent Institutions 17.98 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.49
Short Percentage of Float -
Implied Shares Outstanding 1,489,490,048

Frequently Asked Questions (FAQ)

According to our data, the company BeiGene does not pay dividends yet, even in 2025.

BeiGene shares are traded on the HKSE stock exchange under the ticker: 6160.HK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for BeiGene shares is from a total of 17 analysts. The average target price prediction is 197.82903 HKD per share.

The total number of BeiGene shares on the exchange is 1,285,299,968.00 shares, which at the current market capitalization gives the company a total valuation of 197,506,383,872.00 HKD.